Article Details
Retrieved on: 2022-07-08 12:37:08
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Morgan Stanley increased their target price on Axsome Therapeutics from $27.00 to $54.00 and gave the stock an "equal weight" rating in a research ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here